Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

2.

Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.

Sawhney MS, McDougall H, Nelson DB, Bond JH.

Dig Dis Sci. 2010 Jun;55(6):1637-42. doi: 10.1007/s10620-010-1150-4. Epub 2010 Mar 3.

PMID:
20195757
3.

Recent nonsteroidal anti-inflammatory drug use increases the risk of early recurrence of bleeding in patients presenting with bleeding ulcer.

Godil A, DeGuzman L, Schilling RC 3rd, Khan SA, Chen YK.

Gastrointest Endosc. 2000 Feb;51(2):146-51.

PMID:
10650255
4.

Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.

Rockey DC, Koch J, Cello JP, Sanders LL, McQuaid K.

N Engl J Med. 1998 Jul 16;339(3):153-9.

5.

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.

J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.

6.
7.

Bleeding risk after invasive procedures in aspirin/NSAID users: polypectomy study in veterans.

Manocha D, Singh M, Mehta N, Murthy UK.

Am J Med. 2012 Dec;125(12):1222-7. doi: 10.1016/j.amjmed.2012.05.030.

PMID:
23164486
8.

Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Lieberman N, Klang S, Niv Y.

Am J Gastroenterol. 2009 Apr;104(4):933-8. doi: 10.1038/ajg.2009.14. Epub 2009 Mar 17.

PMID:
19293792
9.

Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals.

MartĂ­nez ME, McPherson RS, Levin B, Annegers JF.

Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):703-7.

10.

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.

Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A; Women's Health Initiative.

Cancer Res. 2003 Sep 15;63(18):6096-101.

11.

[Clinical usefulness of fecal occult blood test as a screening method for asymptomatic patients with colon polyps].

Lee SH, Lee KS, Lee JY, Ji JH, Park JK, Park YS, Hwang JH, Kim JW, Jung SH, Kim N, Lee DH, Kim SG, Kim JS, Jung HC, Song IS.

Korean J Gastroenterol. 2006 Dec;48(6):388-94. Korean.

12.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

14.
15.

Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas.

Sandler RS, Galanko JC, Murray SC, Helm JF, Woosley JT.

Gastroenterology. 1998 Mar;114(3):441-7.

PMID:
9496933
16.
17.
18.

Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.

Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):261-4.

19.

[Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].

VestergÄrd A, Bredahl K, de Muckadell OB, Pedersen OB, Hansen JM.

Ugeskr Laeger. 2009 Jan 19;171(4):235-9. Danish.

PMID:
19174039
20.

Aspirin use in relation to risk of prostate cancer.

Leitzmann MF, Stampfer MJ, Ma J, Chan JM, Colditz GA, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1108-11.

Items per page

Supplemental Content

Write to the Help Desk